Literature DB >> 3883183

Drug therapy. Serum bactericidal activity as a monitor of antibiotic therapy.

J S Wolfson, M N Swartz.   

Abstract

Mesh：

Substances：

Year:  1985        PMID： 3883183     DOI： 10.1056/NEJM198504113121507

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.

Authors:  L Aguilar; J Rosendo; I P Balcabao; M Martín; M J Giménez; J Frías; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

Review 2.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 3.  Serum bactericidal test.

Authors:  C W Stratton
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  Comparative study of serum bactericidal activity of cefotaxime alone or in combination with tobramycin.

Authors:  M G Bergeron; M LeBel; A Charest; J F Forcier; J Morin; F Vallée
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

5.  Influence of technical factor variations on serum inhibition and bactericidal titers.

Authors:  B F Woolfrey; R T Lally; K R Tait
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

6.  Endocarditis with Moraxella-like M-6 after cardiac catheterization.

Authors:  R E Perez
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

7.  Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.

Authors:  P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

8.  Comparative serum bactericidal activities of three doses of ciprofloxacin administered intravenously.

Authors:  M Dan; F Poch; C Quassem; R Kitzes
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Pharmacokinetics and bactericidal activities of one 800-milligram dose versus two 400-milligram doses of intravenously administered pefloxacin in healthy volunteers.

Authors:  O Petitjean; B Pangon; N Brion; M Tod; C Chaplain; V Le Gros; K Louchahi; P Allouch
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.

Authors:  W Paulfeuerborn; H J Müller; K Borner; P Koeppe; H Lode
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.